Investing in the Revolution

Novo Aetas is at the forefront of the biotechnology revolution. We invite you to be a part of our journey as we unlock the potential of genomics to create a healthier and more sustainable world.

Investors

Financial Highlights

We are committed to delivering long-term value to our shareholders through sustainable growth and innovation.

50%

YoY Revenue Growth

$25M

Series A Funding

10+

Patents Filed

Corporate Governance

Leadership & Accountability

Our leadership team is committed to the highest standards of corporate governance and ethical conduct.

Board of Directors

Our board comprises experienced leaders from the technology and healthcare sectors.

Audit Committee

Ensuring financial transparency and accountability.

SEC Filings

Access our latest financial reports and filings.

Investor FAQ

Find answers to frequently asked questions from our investors.